Comparative effects of treatment with ferric carboxymaltose versus ferric derisomaltose in a murine model of iron-deficiency anemia

被引：0
|
作者：
Rieg, Jessica Dominguez
Xue, Jianxiang
Thomas, Linto
Rieg, Timo
机构：
来源：
PHYSIOLOGY | 2023年 / 38卷
关键词：
iron; phosphate;
D O I：
10.1152/physiol.2023.38.S1.5733346
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Abdelazim, Ibrahim A.
    Nusair, Bassam
    Svetlana, Shikanova
    Zhurabekova, Gulmira
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (06) : 1231 - 1232
  • [22] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Froessler, Bernd
    Gajic, Tijana
    Dekker, Gustaaf
    Hodyl, Nicolette A.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (01) : 75 - 82
  • [23] Effects of ferric derisomaltose and ferric carboxymaltose on hypophosphatemia in iron-deficiency anaemia due to Inflammatory Bowel Disease: A Phase IV randomised clinical trial
    Zoller, H.
    Wolf, M.
    Blumenstein, I.
    Primas, C.
    Lindgren, S.
    Thomsen, L. L.
    Reinisch, W.
    Iqbal, I.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S121 - S121
  • [24] Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia
    Breymann, Christian
    Gliga, Flaviu
    Bejenariuc, Christina
    Strizhova, Nina
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 101 (01) : 67 - 73
  • [25] Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
    Adkinson, N. Franklin
    Strauss, William E.
    Macdougall, Iain C.
    Bernard, Kristine E.
    Auerbach, Michael
    Kaper, Robert F.
    Chertow, Glenn M.
    Krop, Julie S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) : 683 - 690
  • [26] Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
    Kanshaiym, Sakiyeva
    Zhurabekova, Gulmira
    Abdelazim, Ibrahim A.
    Starchenko, Tatyana
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 98 - 99
  • [27] Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
    Wolf, Myles
    Rubin, Janet
    Achebe, Maureen
    Econs, Michael J.
    Peacock, Munro
    Imel, Erik A.
    Thomsen, Lars L.
    Carpenter, Thomas O.
    Weber, Thomas
    Brandenburg, Vincent
    Zoller, Heinz
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (05): : 432 - 443
  • [28] Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia
    Ding, Yanhua
    Zhu, Xiaoxue
    Li, Xiaojiao
    Zhang, Hong
    Wu, Min
    Liu, Jingrui
    Palmen, Mary
    Roubert, Bernard
    Li, Cuiyun
    CLINICAL THERAPEUTICS, 2020, 42 (02) : 276 - 285
  • [29] Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron
    Lichtenstein, Gary R.
    Onken, Jane E.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (11) : 3009 - 3019
  • [30] A UK COST-UTILITY ANALYSIS OF FERRIC CARBOXYMALTOSE VERSUS FERRIC DERISOMALTOSE IN PATIENTS WITH IRON DEFICIENCY ANEMIA AND INFLAMMATORY BOWEL DISEASE: INCORPORATION OF FRACTURE DATA
    Zoller, H.
    Pammer, L. M.
    Nottmeier, M.
    Poehlmann, J.
    Pollock, R. F.
    VALUE IN HEALTH, 2024, 27 (06) : S69 - S70
12345